Development of an influenza vaccine using an artificial membrane
Nerome, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 44(8): 1902-1911
1986
ISSN/ISBN: 0047-1852 PMID: 3537379 Document Number: 279760
Document emailed within 1 workday
Related Documents
2000: Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000-01 influenza season. Advisory Committee on Immunization Practices Mmwr. Morbidity and Mortality Weekly Report 49(27): 619-622Fine, M. 2004: The Rhode Island influenza vaccine experience 1995-2003: influenza vaccine price, reimbursement, availability, and Rhode Island's influenza vaccination rate Medicine and Health Rhode Island 87(3): 79-80
Zhdanov, V.M.; Aleksandrova, G.I.; Gendon, I.Z. 1986: Live influenza vaccine in the USSR: its development, study and practical use Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 7: 3-13
Peeters, B. 2008: Bird flu (avian influenza): applicable recombinant DNA techniques in research and vaccine development Tijdschrift Voor Diergeneeskunde 133(22): 956-958
Oxford, J.S. 1991: Antigenic and biochemical studies of influenza viruses isolated in defined community epidemics have allowed the development of a new experimental inactivated vaccine Progress in Medical Virology. Fortschritte der Medizinischen Virusforschung. Progres en Virologie Medicale 38: 180-203
Nekliudova, L.I.; Fedorova, I.B.; Orlova, N.G. 1974: Correlation of antineuraminidase antibodies and antihemagglutinins in influenza and following administration of live influenza vaccine Voprosy Virusologii 2: 173-176
1995: CDC releases update on influenza activity and on composition of 1995-96 influenza vaccine American Family Physician 52(1): 298-299
Hahn, H.L.; Mössner, J. 1980: Influenza vaccination of risk patients with trivalent split virus vaccine and subunit vaccine Münchener Medizinische Wochenschrift 122(42): 1477-1480
Hannoun, C. 1973: A new step in influenza vaccination. I. Prospective vaccine against influenza La Nouvelle Presse Medicale 2(18): 1199-1202
Alvarez-Alva, R. 1971: Epidemiologic study on the 1969-1970 influenza outbreak and the antigenic capacity of anti-influenza vaccine. I. Methodology of the epidemiological studies Gaceta Medica de Mexico 101(1): 21-26
Tsuno, K.; Terasaki, H.; Saito, Y.; Sakai, K.; Kishi, Y.; Sakanashi, Y.; Morioka, T. 1986: Concentration of oxygen for an artificial membrane lung and the safety of prolonged extracorporeal membrane oxygenation Masui. Japanese Journal of Anesthesiology 35(10): 1528-1535
Guo, W.; Xu, J.; Wu, J.; Zhao, S.; He, H.; Shi, W.; Yu, D.; Li, J.; Gao, H.; Chen, J. 2014: Safety and immunogenicity of seasonal inactivated influenza vaccine (split virion) and cross-reactive antibody responses to the H7N9 avian influenza virus Zhonghua Liu Xing Bing Xue Za Zhi 35(8): 949-952
LaForce, F.M. 2011: Technology transfer to developing country vaccine manufacturers to improve global influenza vaccine production: a success story and a window into the future Vaccine 29(Suppl 1): A1
Petrescu, A.; Mihail, A.; Samuel, I.; Teodosiu, O.; Isaia, G.; Ganea, E.; Motaş, C. 1979: Neutralizing influenza antibodies, IgA and total protein in the nasopharyngeal secretions of subjects vaccinated by nasal route with the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology Virologie 30(2): 109-115
Cassetti, M.Cristina.; Katz, J.M.; Wood, J. 2006: Report of a consultation on role of immunological assays to evaluate efficacy of influenza vaccines. Initiative for Vaccine Research and Global Influenza Programme, World Health Organization, Geneva, Switzerland, 25 January 2005 Vaccine 24(5): 541-543
2000: From the Centers for Disease Control and Prevention. Update: Influenza activity--United States, and worldwide, 1999-2000 season, and composition of the 2000-2001 influenza vaccine JAMA 283(21): 2781-2783
Yanagita, M.; Kuwamura, Y.; Kinoshita, S.; Nakajima, T.; Tomizawa, S.; Ozawa, T. 2015: Development of a Real-Time Reverse Transcription PCR Assay System for Detection of Three Subtypes of Influenza a and Influenza B Viruses Rinsho Byori. Japanese Journal of Clinical Pathology 63(12): 1365-1370
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452